The Magic Mushrooms and MDMA market is hitting new milestones. Canada has licensed Optimi Health Corp. (OTC:OPTHF) to export psilocybin and MDMA to Australia, marking a significant step in the medical psychedelic drugs market. This license allows the Vancouver-based startup to ship controlled substances for patient use. This development positions Optimi among a select group of legal international suppliers of psychedelic drugs, aiming to become a relevant player in the manufacture of pharmaceutical-grade psychs. Industry Impact and InvestmentOptimi Health’s vision focuses on the potential of p…
